本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Actinium Pharmaceuticals, Inc.

1.31
+0.04003.15%
盤後1.26-0.0500-3.82%19:46 EDT
成交量:32.26萬
成交額:41.46萬
市值:4,086.66萬
市盈率:-1.03
高:1.36
開:1.23
低:1.21
收:1.27
資料載入中...
2022/12/30

重要事件披露

8-K - Current report
2022/12/09

重要事件披露

8-K - Current report
2022/11/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/10/31

重要事件披露

8-K - Current report
2022/08/19

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/08/12

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/29

重要事件披露

8-K - Current report
2022/05/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/04/13

重要事件披露

8-K - Current report
2022/03/25

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/09/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/07/30

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/03/31

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals